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Abstract
Pulmonary fibrosis is characterized by lung fibroblast proliferation and collagen secretion. In lipopolysaccharide (LPS)-
induced acute lung injury (ALI), aberrant proliferation of lung fibroblasts is initiated in early disease stages, but the
underlying mechanism remains unknown. In this study, we knocked down Toll-like receptor 4 (TLR4) expression in cultured
mouse lung fibroblasts using TLR4-siRNA-lentivirus in order to investigate the effects of LPS challenge on lung fibroblast
proliferation, phosphoinositide3-kinase (PI3K)-Akt pathway activation, and phosphatase and tensin homolog (PTEN)
expression. Lung fibroblast proliferation, detected by BrdU assay, was unaffected by 1 mug/mL LPS challenge up to
24 hours, but at 72 hours, cell proliferation increased significantly. This proliferation was inhibited by siRNA-mediated TLR4
knockdown or treatment with the PI3K inhibitor, Ly294002. In addition, siRNA-mediated knockdown of TLR4 inhibited the
LPS-induced up-regulation of TLR4, down-regulation of PTEN, and activation of the PI3K-Akt pathway (overexpression of
phospho-Akt) at 72 hours, as detected by real-time PCR and Western blot analysis. Treatment with the PTEN inhibitor,
bpV(phen), led to activation of the PI3K-Akt pathway. Neither the baseline expression nor LPS-induced down-regulation of
PTEN in lung fibroblasts was influenced by PI3K activation state. PTEN inhibition was sufficient to exert the LPS effect on
lung fibroblast proliferation, and PI3K-Akt pathway inhibition could reverse this process. Collectively, these results indicate
that LPS can promote lung fibroblast proliferation via a TLR4 signaling mechanism that involves PTEN expression down-
regulation and PI3K-Akt pathway activation. Moreover, PI3K-Akt pathway activation is a downstream effect of PTEN
inhibition and plays a critical role in lung fibroblast proliferation. This mechanism could contribute to, and possibly
accelerate, pulmonary fibrosis in the early stages of ALI/ARDS.
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Introduction
Pulmonary fibrosis is characterized by aberrant proliferation
and activation of lung fibroblasts and collagen secretion that
results in excessive extracellular matrix (ECM) deposition [1,2].
The process of pulmonary fibrosis can be stimulated by pathogen
infection, wherein the host cells recognize and respond to
pathogen-associated molecular patterns (PAMPs). One of the
most well characterized PAMPs is the lipopolysaccharide (LPS)
component of the outer membrane of Gram-negative bacteria.
LPS exerts its biological effects on the host by binding to Toll-like
receptor 4 (TLR4), a pattern recognition receptor (PPR) that is
widely distributed among lung parenchyma cells, including
macrophages, epithelial cells, and fibroblasts. Our previous studies
have shown that LPS plays an important role in the development
of acute lung injury (ALI), acute respiratory distress syndrome
(ARDS), and pulmonary fibrosis, through activation of TLR4 and
its downstream intracellular signal transduction pathways [3,4]. In
addition, our study and those by others have also determined that
focal aggregation of lung fibroblasts occurs prior to formation of
fibrosis [5], implying that aberrant proliferation of fibroblasts takes
place in the early stages of ALI/ARDS. However, the mechanisms
underlying fibroblast proliferation remain unknown.
In another previous in vitro study from our lab, we determined
that LPS was able to directly induce secretion of collagen in
primary cultured mouse lung fibroblasts via TLR4-mediated
activation of the phosphoinositide3-kinase-Akt (PI3K-Akt) path-
way [6]. This finding raised the questions of whether LPS directly
affects lung fibroblast proliferation, and which factors or signaling
mechanisms are involved. Several recent studies have revealed that
the PI3K-Akt pathway is closely related to cell cycle regulation
[7,8,9]. The tumor suppressor phosphatase and tensin homolog
(PTEN) acts to dephosphorylate phosphatidylinositol (3,4,5)-
trisphosphate (PIP3), resulting in inhibition of the PI3K-Akt
pathway. Low expression of PTEN and activation of the PI3K-Akt
pathway have been found in lung fibroblasts from patients with
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LPS may promote lung fibroblast proliferation by down-regulating
PTEN expression and activating the PI3K-Akt pathway in the
early stages of ALI/ARDS.
We used the knowledge and model system from our previous
research to investigate this new hypothesis. Specifically, we
knocked down TLR4 expression in cultured mouse lung
fibroblasts using lentivirus-based RNA interference (RNAi), and
then systematically evaluated the effect of LPS challenge on lung
fibroblast proliferation, PTEN expression, and TLR4-mediated
PI3K-Akt pathway activation.
Materials and Methods
Ethics statement
This study was approved by the Animal Care and Use
Committee of the Shanghai Jiaotong University School of
Medicine. All procedures were carried out in accordance with
the guidelines for animal care published by the United States’
National Institutes of Health (NIH) for animal care (Guide for the
Care and Use of Laboratory Animals, Department of Health and
Human Services, NIH Publication No. 86-23, revised 1985).
Primary cultures of mouse lung fibroblasts
Lung fibroblasts were isolated from a C57/BL6 mouse, as
described in our previous study [6]. Briefly, an eight-week-old
mouse (Shanghai SLAC Laboratory Animal Co. Ltd., China) was
sacrificed by decapitation. Lung tissues were promptly excised,
washed with phosphate buffered saline (PBS), and cut to 1 mm
3-
sized tissue masses. Tissues were then distributed evenly along the
bottom of culture plates and covered with Dulbecco’s Modified
Eagle’s Medium (DMEM) containing 10% calf serum (Gibco,
USA). The plates were cultured at 37uC in a humidified 5% CO2
incubator (Labotect, Germany), and DMEM was changed every
three days. When the cultures reached 80% confluence, adherent
cells were detached by exposure to 0.25% trypsin for five minutes,
and then passaged at a 1:4 dilution. Cells grew to a typical fusiform
shape after four generations. Fibroblasts were characterized as
previously described [12], and then used from passages five and
seven.
Construction and identification of RNAi lentivirus vector
targeting the TLR4 gene
A TLR4-specific RNAi lentivirus vector (TLR4-siRNA-lentivi-
rus) was constructed and verified by the Shanghai GeneChem Co.
Ltd. (China), as described in our previous study [6].
Experimental design and treatment
Purified mouse lung fibroblasts in DMEM containing 10% calf
serum were seeded into 96-well plates and grown in a humidified
atmosphere containing 5% CO2. When ,60% confluence was
reached, the medium was replaced with serum-free medium and
the cultures were incubated for an additional 24 hours at 37uCi n
5% CO2. Finally, the serum-free medium was replaced with
DMEM containing 10% calf serum and the cells were divided
among several groups for various experimental manipulations, as
detailed below:
To inhibit expression of TLR4 mRNA in lung fibroblasts,
TLR4-siRNA-lentivirus was added to cells at a concentration of
1610
8 TU/mL for 48 hours. Negative controls were established
by adding the same doses of negative control-siRNA-lentivirus
containing scrambled nonfunctional RNAi sequences. To inhibit
activation of the PI3K-Akt pathway, the PI3K inhibitor Ly294002
(CST, USA) was added to cells at a concentration of 50 mmol/L
and incubated for one hour. To inhibit activation of PTEN, cells
were exposed to PTEN inhibitor (1 mM bpV(phen); Alexis, USA)
for 0.5 hour. To investigate the effect of LPS challenge on lung
fibroblast proliferation, purified LPS (derived from O55:B5 E. coli;
Sigma, USA) was added to cells at a concentration of 1 mg/mL
and incubated for 72 hours (or the time indicated in the figures).
Experiments were performed three times in each group. Cells were
collected for measurements at 72 hours (or the time indicated in
the figures) after LPS stimulation. Cell proliferation was assessed
by the BrdU assay. The mRNA and protein expression of TLR4,
PTEN, and phosphorylated Akt were examined by real-time PCR
or Western blot analysis, respectively.
Cell proliferation assay
To evaluate lung fibroblast proliferation after different treat-
ments, quantification of DNA synthesis, a direct indication of cell
proliferation, was assessed by the BrdU cell proliferation assay, as
previously described [11]. Briefly, prior to harvesting, cells were
incubated with BrdU for four hours. Anti-BrdU antibody was
applied as an immuno-stain, according to the manufacturer’s
instructions (CST). DNA synthesis was quantified by the
magnitude of absorbance (optical density, OD) at 450 nm, which
was proportional to the quantity of BrdU incorporated into cells.
Real-time PCR
The mRNA expression of TLR4 and PTEN was analyzed by
real-time PCR. Total RNA was isolated from cells with the
RNeasy kit using the Trizol reagent (Invitrogen, USA) and was
reverse-transcribed into cDNA with a reverse transcription kit
using M-MLV polymerase (Promega, USA). Sequence-specific
primers were: GAPDH-F: 59- TGGTGAAGGTCGGTGT-
GAAC-39, GAPDH-R: 59-GCTCCTGGAAGATGGTGATGG-
39; TLR4-F: 59-ATGGCATGGCTTACACCACC-39, TLR4-R:
59-GAGGCCAATTTTGTCTCCACA-39; PTEN-F: 59-CCA-
TAACCCACCACAGC-39, PTEN -R: 59-AGTCCGTCCCT-
TTCCAG-39. Real-time PCR was performed on the IQ5 PCR
System (Bio-Rad, USA) with an initial denaturing step at 95uC for
15 seconds, 35 cycles of denaturing at 95uC for 5 seconds, and
annealing at 55uC for 30 seconds. Relative expression of real-time
PCR products was determined by the DDCt method [13] to
normalize target gene expression to that of the housekeeping gene
(GAPDH).
Western blot analysis
Expression of TLR4, PTEN, Akt, and Ser473 phospho-Akt, was
detected by Western blotting. Cells were collected and lysed with
1x RIPA lysis Buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% sodium dodecyl
sulfate (SDS), 5 mM EDTA, 2 mM phenylmethylsulfonyl fluoride
(PMSF), 20 mg/mL aprotinin, 20 mg/mL leupeptin, 10 mg/mL
pepstanin A, 150 mM benzamidine) on ice for 10–15 minutes.
Cell debris was pelleted by centrifugation, and protein-containing
supernatants were collected. Protein quantification was performed
with the BCA method, and SDS-polyacrylamide gel electropho-
resis (PAGE) was performed. Proteins were transferred to
polyvinylfluoride membranes, probed with the appropriate
primary and secondary antibodies, and detected by the ECL+-
plus
TM Western blotting system kit (Amersham, USA). Primary
antibodies (1:1000 dilution) were: mouse anti-TLR4 (ab22048;
Abcam, UK), rabbit anti-p-Akt (Phospho-Akt (Ser473), 4060;
CST), rabbit anti-Akt (4691; CST), rabbit anti-PTEN (9188;
CST), and mouse anti-GAPDH (sc-32233; Santa Cruz Biotech-
nologies, USA). Secondary antibodies (1:5000) were: goat anti-
mouse IgG (sc-2005; Santa Cruz Biotechnologies) and goat anti-
LPS-Induced Lung Fibroblast Proliferation
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35926rabbit IgG (sc-2004; Santa Cruz Biotechnologies). Immunoreac-
tivity was visualized by Perfection 3490 photo gel imaging systems
(Epson, Japan) and analyzed by Image Pro PLUS. Protein
expression was normalized to GAPDH.
Statistical analysis
All data are represented as mean 6 standard deviation (SD).
The SPSS statistical software, version 12.0, was used for mean
value comparisons of single-factor multiple samples. The homo-
geneity of variance data were analyzed with the one-factor analysis
of variance least squares difference (LSD) test, and the heteroge-
neity of variance data were analyzed with the Kruskal Wallis rank
sum test. Statistical significance was defined as p-values less than
0.05.
Results
Effect of LPS on lung fibroblast proliferation
To investigate the effect of LPS on various stages of lung
fibroblast proliferation, we employed the BrdU assay to temporally
quantify DNA synthesis in lung fibroblasts in response to LPS
challenge. Compared to the control group, the amount of DNA
synthesis in lung fibroblasts was increased significantly only at
72 hours after LPS challenge (p,0.05) (Fig. 1).
Expression of TLR4 in lung fibroblasts and its effect on
lung fibroblast proliferation
To investigate TLR4 expression in lung fibroblasts and its effect
on lung fibroblast proliferation, TLR4 mRNA was knocked down
in lung fibroblasts by transfecting TLR4-siRNA-lentivirus. Real-
time PCR and Western blot analysis were used to detect TLR4
mRNA and protein expression, respectively, in lung fibroblasts at
72 hours after LPS challenge. The BrdU assay was used to
quantify DNA synthesis in TLR4-siRNA-lentivirus-transfected
lung fibroblasts. TLR4 mRNA and protein expression in lung
fibroblasts increased significantly at 72 hours after LPS challenge
(Fig. 2A, B). TLR4 mRNA and protein expression were reduced in
lung fibroblasts after TLR4-siRNA-lentivirus transfection, regard-
less of whether LPS challenge was performed, which indicated a
nearly complete inhibitory effect. BrdU assay showed that,
compared to unchallenged cells, DNA synthesis increased
Figure 1. Effect of LPS on lung fibroblast proliferation. DNA
synthesis in lung fibroblasts was detected by BrdU assay after LPS
challenge at 0, 6, 24, and 72 hours. * p,0.05 for percentage of OD450
absorbance compared to the control group at the same time point.
Columns represent mean values (n=3) and error bars represent SD.
doi:10.1371/journal.pone.0035926.g001
Figure 2. Expression of TLR4 in lung fibroblasts and its effect
on lung fibroblast proliferation. TLR4 mRNA (A, real-time PCR) and
protein (B, Western blot) expression in lung fibroblasts at 72 hours after
1 mg/mL LPS challenge. Effect of siRNA-mediated knockdown of TLR4
(1610
8 TU/mL for 48 hours) on lung fibroblast proliferation (C, BrdU
assay). * p,0.05 vs. negative control group (Column 2);
{ p,0.05 vs.
positive control group (Column 3). Columns represent mean values and
error bars represent SD. Blots are representative of three independent
experiments.
doi:10.1371/journal.pone.0035926.g002
LPS-Induced Lung Fibroblast Proliferation
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35926significantly in lung fibroblasts at 72 hours after LPS challenge
(Fig. 2C). However, no differences were observed when the cells
were transfected with the TLR4-siRNA-lentivirus.
Expression of PTEN in lung fibroblasts after LPS challenge
or PI3K inhibition
Real-time PCR and Western blot analysis showed that PTEN
mRNA and protein expression was decreased significantly in lung
fibroblasts at 72 hours after LPS challenge (Fig. 3A, C). However,
no difference was observed after TLR4-siRNA-lentivirus transfec-
tion. To elucidate whether PTEN expression is regulated by PI3K
activation, LPS-induced inhibition of PTEN expression was
investigated in the presence of PI3K inhibitor Ly294002.
Ly294002 treatment had no effect on PTEN expression in either
normal lung fibroblasts or LPS-challenged lung fibroblasts (Fig. 3B,
D).
Effect of PI3K-Akt pathway and PTEN on lung fibroblast
proliferation
PI3K-Akt pathway activation in lung fibroblasts in response to
LPS challenge was assessed by Western blot measurement of the
Akt phosphorylation product, Ser473 phospho-Akt. PI3K-Akt
pathway activation was also used to evaluate the suppression
efficiency of PTEN inhibitor bpV(phen) in lung fibroblasts, as
described previously [14]. Seventy-two hours after LPS challenge,
the BrdU assay was used to quantify DNA synthesis in bpV(phen)
and/or Ly294002-treated lung fibroblasts. Compared to unchal-
lenged cells, LPS-challenged lung fibroblasts showed significantly
increased phospho-Akt at 72 hours (Fig. 4A). However, TLR4-
siRNA-lentivirus transfection had no effect on phospho-Akt
expression, either with or without LPS challenge. Phospho-Akt
expression was reduced in all Ly294002-treated lung fibroblasts,
regardless of whether the cells had been challenged with LPS,
which indicated a nearly perfect inhibitory effect. Since the
Figure 3. Expression of PTEN in lung fibroblasts after LPS challenge or PI3K inhibition. PTEN mRNA (A and B, real-time PCR) and protein
(C and D, Western blot) expression in lung fibroblasts at 72 hours after 1 mg/mL LPS challenge (A, C) or PI3K-Akt pathway inhibition (B, D). siRNA-
mediated knockdown of TLR4 (1610
8 TU/mL for 48 hours) was used to assess the effect of TLR4 on PTEN expression in lung fibroblasts. Ly294002
(50 mmol/L for one hour) was applied to determine whether PTEN expression is regulated by PI3K activation. * p,0.05 vs. positive control group (A
and C, Column 3). * p,0.05 vs. negative control group (B and D, Column 1);
{ p,0.05 vs. positive control group (Column 2). Columns represent mean
values and error bars represent SD. Blots are representative of three independent experiments.
doi:10.1371/journal.pone.0035926.g003
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independent (Fig. 4B), the 1 mM concentration was selected for
all subsequent analysis. Both LPS challenge and bpV(phen)
treatment led to significantly increased DNA synthesis in lung
fibroblasts, as compared to unchallenged cells (Fig. 4C). However,
these effects could be reduced or even be reversed by Ly294002
treatment.
Discussion
Aberrant proliferation of lung fibroblasts has been detected in
bleomycin-induced lung fibrosis [15], patients with IPF [11], and
LPS-induced ALI and pulmonary fibrosis [4]. Similarly, LPS-
challenged C57BL/6 mice presented with cell proliferation in the
airways [16]. It is generally accepted that lung fibroblasts develop
the property of aberrant proliferation under certain pathological
conditions, but the underlying mechanism remains poorly
understood. Our present study revealed that LPS can directly
induce lung fibroblast proliferation through TLR4 signaling and
downstream activation of the PI3K-Akt pathway. Moreover, our
results indicated that LPS-activated TLR4 signaling may lead to
down-regulation of PTEN, effectively supporting the cell prolifer-
ation process.
Recent studies have provided evidence that TLR4 is expressed
on lung fibroblasts [6,17]; however, there is considerable
controversy about the effect of LPS challenge on fibroblast
proliferation. Yang et al. reported that LPS is able to significantly
stimulate human skin fibroblast proliferation after more than six
days of incubation [18]. Similar results were obtained from
cultured human small intestinal lamina propria fibroblasts [19],
adventitial fibroblasts [20,21], 3T6 fibroblasts [22], human
periodontal ligament fibroblasts (HPLF) [23], and lamina propria
fibroblasts [24]. Human gingival fibroblasts and rat embryo
fibroblasts, however, yielded opposite results [25,26,27,28]. Zhang
et al. demonstrated that LPS can have a dose-dependent inhibitory
effect on fibroblast proliferation at 24 hours after LPS challenge
[29]. In our present study, LPS challenge of primary cultured
mouse lung fibroblasts had no effect on proliferation for up to
24 hours; however, unlike the results from Zhang et al., the lung
fibroblasts in our study underwent significant proliferation at
72 hours after LPS challenge. This time point coincides with the
period in our previous study when lung fibroblast proliferation and
activation were observed in the animal model of LPS-induced ALI
and pulmonary fibrosis [4]. Previous clinical research also
indicated that lung fibroblast collagen secretion occurred in early
stage ALI/ARDS [30]. Therefore, we conclude that LPS can
directly promote lung fibroblast proliferation under certain
pathophysiologic conditions. It is possible that distinct fibroblast
subpopulations [31] or different experimental strategies [32,33]
may account for the inconsistent results reported in the literature.
Subsequent studies should be carried out to elucidate the detailed
mechanisms through which LPS exerts its effects on the lung
Figure 4. Effect of PI3K-Akt pathway activation and PTEN
expression on lung fibroblast proliferation. Activation of PI3K-Akt
pathway (A, Western blot) in lung fibroblasts at 72 hours after 1 mg/mL
LPS challenge, as detected by expression of Ser473 phospho-Akt.
siRNA-mediated TLR4 knockdown (1610
8 TU/mL for 48 hours) was used
to assess the effect of TLR4 on PI3K-Akt pathway activation. PI3K
inhibitor Ly294002 (50 mmol/L for one hour) was used to assess the
effect of PI3K-Akt pathway on lung fibroblast proliferation. * p,0.05 vs.
negative control group (Column 2);
{ p,0.05 vs. positive control group
(Column 3). Activation of PI3K-Akt pathway in lung fibroblasts (B,
Western blot), as detected by expression of Ser473 phospho-Akt after
treatment with different concentrations of PTEN inhibitor bpV(phen) for
0.5 hour. * p,0.05 vs. negative control group (Column 1). DNA
synthesis (C, BrdU assay) in LPS-challenged lung fibroblasts after
bpV(phen) (1 mM for 0.5 hour) and/or Ly294002 (50 mmol/L for one
hour) treatment. * p,0.05 vs. negative control group (Column 1);
{
p,0.05 vs. positive control group (Column 2). Columns represent mean
values and error bars represent SD. Blots are representative of three
independent experiments.
doi:10.1371/journal.pone.0035926.g004
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conditions.
TLR4 is an important LPS-specific receptor that is widely
distributed among pulmonary cells. LPS-mediated activation of
the TLR4 signaling pathway involves several key pathways
associated with ALI/ARDS and pulmonary fibrosis, including
the PI3K-Akt pathways [34]. Previous studies have shown that
activation of TLR4 signaling, including downstream activation of
the PI3K-Akt pathway, is strongly correlated to pulmonary cell
cycle regulation [35,36]. Furthermore, the PI3K-Akt pathway has
been shown to mediate radiation-stimulated proliferation of
normal human lung fibroblasts [7] and hypoxia-induced adven-
titial fibroblast proliferation [8], and to inhibit endothelin (ET)-1-
induced fibroblast apoptosis [37]. The present study revealed that
LPS-induced aberrant proliferation of lung fibroblasts is accom-
panied by overexpression of TLR4 and Akt phosphorylation,
indicating activation of the PI3K-Akt pathway. This finding partly
agrees with the results reported by Kim et al. [7], and those from
our previous study [4,6]. siRNA-mediated TLR4 knockdown and
PI3K inhibition by Ly294002 effectively blocked LPS-induced
lung fibroblast proliferation, suggesting that LPS can promote lung
fibroblast proliferation via overexpression of TLR4 and activation
of the PI3K-Akt pathway.
In addition, our study also detected down-regulation of PTEN
expression in lung fibroblasts after LPS challenge. This effect was
inhibited by siRNA-knockdown of TLR4, suggesting that LPS-
induced activation of TLR4 signaling could inhibit expression of
PTEN in lung fibroblasts. The encoded PTEN protein is a tumor
suppressor with phosphatase-like activities that can modulate the
PI3K pathway by catalyzing degradation of PI3K-generated PIP3.
In this manner, PTEN restrains cell proliferation through
inhibiting downstream functions of the PI3K-Akt pathway
[38,39]. PTEN is robustly expressed in normal lung fibroblasts,
where it is believed to prevent aberrant proliferation and
activation during injury repair [40]; indeed, aberrant fibroblast
proliferation and activation in IPF patients was accompanied by
low expression of PTEN and activation of the PI3K-Akt pathway
[10,11]. Thus, it is possible that a deficiency in PTEN expression
could result in a more durable fibroproliferative response and
pathological fibrosis. In our study, we found that the PI3K-Akt
pathway is activated and PTEN expression is simultaneously
suppressed in response to LPS challenge. In addition, it was
determined that the PI3K-Akt pathway activation is downstream
of PTEN inhibition, and that the PI3K-Akt pathway represents a
key mechanism of the lung fibroblast proliferation process.
Therefore, LPS-induced TLR4 signaling may activate the PI3K-
Akt pathway by down-regulating PTEN expression in lung
fibroblasts. Since the regulatory effect of PTEN on the PI3K-
Akt pathway is also closely related to its extent of dephosphor-
ylation and phosphatase activity, further investigation should be
carried out to elucidate the role that PTEN plays in LPS-induced
lung fibroblast proliferation.
In conclusion, our study provides evidence that LPS can
promote lung fibroblast proliferation via TLR4 signaling, perhaps
accelerating pulmonary fibrosis in the early stages of ALI/ARDS.
Furthermore, TLR4-induced down-regulation of PTEN expres-
sion and activation of the PI3K-Akt pathway are involved in this
process.
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